| Literature DB >> 29088237 |
Terry P Haines1,2, Kelly-Ann Bowles3, Deb Mitchell1,2, Lisa O'Brien2,4, Donna Markham5, Samantha Plumb6, Kerry May5, Kathleen Philip7, Romi Haas1,2, Mitchell N Sarkies1,2, Marcelle Ghaly8, Melina Shackell8, Timothy Chiu9, Steven McPhail10, Fiona McDermott11, Elizabeth H Skinner1,8.
Abstract
BACKGROUND: Disinvestment (removal, reduction, or reallocation) of routinely provided health services can be difficult when there is little published evidence examining whether the services are effective or not. Evidence is required to understand if removing these services produces outcomes that are inferior to keeping such services in place. However, organisational imperatives, such as budget cuts, may force healthcare providers to disinvest from these services before the required evidence becomes available. There are presently no experimental studies examining the effectiveness of allied health services (e.g., physical therapy, occupational therapy, and social work) provided on weekends across acute medical and surgical hospital wards, despite these services being routinely provided internationally. The aim of this study was to understand the impact of removing weekend allied health services from acute medical and surgical wards using a disinvestment-specific non-inferiority research design. METHODS ANDEntities:
Mesh:
Year: 2017 PMID: 29088237 PMCID: PMC5663333 DOI: 10.1371/journal.pmed.1002412
Source DB: PubMed Journal: PLoS Med ISSN: 1549-1277 Impact factor: 11.069
Fig 1Trial design and occasions of allied health service delivery on weekdays and weekends within each month of the trial.
Numbers in boxes indicate occasions of service provided by allied health team on weekdays/on weekends that month. These data include approved clinical exceptions during no weekend service periods.
Fig 2CONSORT flow chart of site, ward, and patient involvement in data collection and analysis.
Participant demographics for each group within each trial.
| Characteristic | Trial 1 | Trial 2 | ||
|---|---|---|---|---|
| Current weekend service | No weekend service | No weekend service | Newly developed weekend service | |
| 8,038 | 6,796 | 6,869 | 5,805 | |
| Age (years)—mean (SD) | 59.5 (20.7) | 60.8 (20.2) | 59.7 (20.6) | 59.8 (20.3) |
| Sex— | 4,225 (53.6%) | 3,611 (53.1%) | 3,587 (52.2%) | 3,090 (53.2%) |
| Most common Australian Refined Diagnosis Related Groups— | Other digestive system disorders, 267 (3.3%); respiratory infections and inflammations, 214 (2.6%); heart failure and shock, 211 (2.6%); chronic obstructive airways disease, 208 (2.6%) | Chronic obstructive airways disease, 250 (3.7%); respiratory infections and inflammations, 248 (3.7%); other digestive system disorders, 202 (3.0%); septicaemia, 192 (2.8%) | Other digestive system disorders, 237 (3.5%); septicaemia, 198 (2.9%); chronic obstructive airways disease, 179 (2.6%); respiratory infections and inflammations, 178 (2.6%) | Other digestive system disorders, 194 (3.3%); chronic obstructive airways disease, 162 (2.8%); respiratory infections and inflammations, 153 (2.6%); laprascopic cholecystectomy, 145 (2.4%) |
| Expected length of stay (days) | 5.3 (5.1) | 5.7 (5.1) | 5.0 (4.5) | 5.4 (5.6) |
*Based on mean inlier Australian Refined Diagnosis Related Groups from Victoria in 2013.
Raw data for primary and secondary outcomes.
| Outcome | Trial 1 | Trial 2 | ||
|---|---|---|---|---|
| Current weekend service | No weekend service | No weekend service | Newly developed weekend service | |
| 5.5 (7.5)/3.1 (1.5 to 6.4) | 6.3 (9.4)/3.7 (1.7 to 7.2) | 5.0 (5.9)/3.2 (1.6 to 6.1) | 5.9 (8.3)/3.4 (1.6 to 6.9) | |
| 3,263 (40.2%) | 2,608 (38.4%) | 2767 (40.3%) | 2288 (39.4%) | |
| 788 (9.8%) | 733 (10.8%) | 671 (9.8%) | 577 (9.9%) | |
| Any adverse event— | 685 (8.5%) | 665 (9.8%) | 608 (8.9%) | 506 (8.7%) |
| Fall— | 165 (2.1%)/212 | 140 (2.1%)/181 | 156 (2.3%)/218 | 88 (1.5%)/105 |
| Code Blue/MET call— | 300 (3.7%)/400 | 323 (4.7%)/461 | 263 (3.8%)/345 | 274 (4.7%)/380 |
| Pulmonary embolus— | 17 (0.2%)/17 | 11 (0.2%)/11 | 10 (0.2%)/10 | 4 (0.1%)/5 |
| Deep vein thrombosis— | 8 (0.1%)/8 | 7 (0.1%)/8 | 8 (0.1%)/8 | 4 (0.1%)/5 |
| Death— | 143 (1.8%) | 171 (2.5%) | 135 (2.0%) | 120 (2.1%) |
| Pressure area— | 80 (1.0%)/99 | 72 (1.1%)/78 | 58 (0.8%)/61 | 26 (0.5%)/28 |
| ICU admission from the ward— | 154 (1.9%)/167 | 172 (2.5%)/197 | 146 (2.1%)/157 | 153 (2.6%)/173 |
| Home/private residence— | 6,566 (81.7%) | 5,468 (80.5%) | 5,367 (78.1%) | 2,758 (82.0%) |
| Aged care facility— | 142 (1.8%) | 159 (2.3%) | 171 (2.5%) | 137 (2.4%) |
| Other acute/extended care/rehab hospital— | 693 (8.6%) | 579 (8.5%) | 663 (9.7%) | 451 (7.8%) |
| 8,446 (11,205)/5,095 (2,688 to 10,168) | 9,501 (13,661)/5,550 (2,988 to 10,796) | 8,233 (9,942)/5,223 (2,797 to 100,062) | 9,442 (14,794)/5,334 (3,001 to 10,153) | |
| Total | 32 | 33 | 38 | 24 |
| Allied health specific | 1 | 3 | 2 | 0 |
| Total | 37 | 32 | 33 | 43 |
| Allied health specific | 0 | 0 | 1 | 1 |
*Cost in Australian dollars.
£Data from first month of trial only.
€Data from last month of trial only.
ICU, intensive care unit; MET, Medical Emergency Team.
Effect size estimates of main and trial-by-site interaction effects from each trial for primary and secondary outcomes.
| Outcome | Trial 1 | Trial 2 | ||||||
|---|---|---|---|---|---|---|---|---|
| Main effect | Inferiority | Intervention-by-site interaction | ICC | Main effect | Inferiority | Intervention-by-site interaction | ICC | |
| Length of stay (days) | 1.31 (0.85 to 1.77) | Uncertain inferiority | 0.03 (−0.57 to 0.63) | S: 0.0001 | −1.59 (−2.03 to −1.13) | Non-inferior | 0.23 (−0.42 to 0.88) | S: <0.0001 |
| Length of stay (log transformed) | 0.09 (0.04 to 0.15) | N/A | −0.07 (−0.15 to 0.01) | S: <0.0001 | −0.14 (−0.21 to −0.08) | N/A | −0.03 (−0.13 to 0.06) | S: 0.02 |
| Proportion of patients staying longer than expected | 0.01 (−0.01 to 0.04) | Uncertain inferiority | −0.02 (−0.06 to 0.02) | S: 0.83 | −0.02 (−0.05 to −0.01) | Non-inferior | −0.02 (−0.07 to 0.02) | S: 0.85 |
| Proportion with an unplanned readmission within 28 days | 0.01 (−0.01 to 0.03) | Uncertain inferiority | −0.04 (−0.06 to −0.02) | S: <0.0001 | −0.01 (−0.02 to 0.01) | Non-inferior | −0.02 (−0.05 to 0.01) | S: <0.0001 |
| Proportion of patients with any adverse event | 0.01 (−0.01 to 0.03) | Uncertain inferiority | −0.02 (−0.04 to 0.01) | S: <0.0001 | −0.03 (−0.05 to −0.004) | Non-inferior | 0.02 (−0.01 to 0.05) | S: <0.0001 |
| Proportion of patients discharged to aged care facility | 0.001 (−0.004 to 0.01) | N/A | −0.003 (−0.01 to 0.01) | S: 0.30 | −0.001 (−0.01 to 0.01) | N/A | 0.008 (−0.01 to 0.01) | S: 0.12 |
| Cost to the healthcare system per admission (Australian dollars) | 1,810 (1,094 to 2,525) | N/A | 769 (−168 to 1,706) | S: <0.0001 | −2,431 (−3,166 to −1,696) | N/A | −163 (−1,273 to 947) | S: <0.0001 |
| Proportion of patients discharged on a Saturday or Sunday | 0.01 (−0.01 to 0.03) | N/A | 0.02 (−0.01 to 0.05) | S: <0.0001 | −0.02 (−0.05 to −0.002) | N/A | −0.01 (−0.04 to 0.02) | S: <0.0001 |
Main effects are interpreted as the impact of being exposed to the ‘no weekend’ allied health condition compared to the ‘current’ or ‘newly developed’ weekend allied health conditions. Data in parentheses are 95% CIs.
*Intraclass correlation coefficients (ICCs) derived from mixed-effects generalised linear models partitioned at the site (S), ward (W), and patient episode (E) levels.
£Statistically significant (superiority hypothesis, 2-tailed p < 0.05).
N/A, not applicable.
Effect size estimates of main effects from the exploratory analyses.
| Outcome | Weekend service: ‘current’ versus ‘newly developed’ | No weekend service: Trial 1 versus Trial 2 | Sensitivity: Trial 1 with 1-month washout period | ||||
|---|---|---|---|---|---|---|---|
| Effect size | ICC | Effect size | ICC | Effect size | Inferiority | ICC | |
| Length of stay (days) | 0.12 (−0.20 to 0.43) | S: 0.0002 | 1.03 (0.73 to 1.32) | S: <0.0001 | 0.30 (0.01 to 0.60) | Non-inferior | S: <0.0001 |
| Length of stay (log transformed) | 0.05 (0.01 to 0.09) | S: 0.0001 | 0.11 (0.07 to 0.15) | S: 0.0001 | 0.05 (0.02 to 0.09) | N/A | S: <0.0001 |
| Proportion of patients staying longer than expected | 0.01 (−0.01 to 0.04) | S: 0.83 | 0.01 (−0.003 to 0.03) | S: 0.87 | 0.03 (−0.004 to 0.06) | Uncertain inferiority | S: 0.83 |
| Unplanned readmission within 28 days | 0.01 (−0.01 to 0.02) | S: <0.0001 | −0.001 (−0.02 to 0.01) | S: <0.0001 | 0.01 (−0.01 to 0.03) | Uncertain inferiority | S: <0.0001 |
| Proportion of patients with any adverse event | −0.002 (−0.01 to 0.01) | S: 0.02 | 0.02 (0.008 to 0.04) | S: <0.0001 | 0.01 (−0.01 to 0.03) | Uncertain inferiority | S: <0.0001 |
| Proportion of patients discharged to aged care | −0.004 (−0.01 to 0.003) | S: 0.14 | −0.01 (−0.01 to 0.003) | S: 0.23 | −0.001 (−0.01 to 0.01) | N/A | S: 0.31 |
| Cost to the healthcare system per admission (Australian dollars) | −558 (−1,086 to −30) | S: 0.0001 | 1,224 (745 to 1,702) | S: 0.0001 | 952 (494 to 1,410) | N/A | S: 0.0001 |
| Proportion of patients discharged on a Saturday or Sunday | −0.01 (−0.04 to 0.02) | S: <0.0001 | 0.05 (−0.01 to 0.10) | S: <0.0001 | 0.02 (−0.004 to 0.04) | N/A | S: <0.0001 |
Main effects are interpreted as the impact of being exposed to the ‘current’ service, exposure to Trial 1, and exposure to the ‘current’ service for the three analyses, respectively. Data in parentheses are 95% CIs.
*Intraclass correlation coefficients (ICCs) derived from mixed-effects generalised linear models partitioned at the site (S), ward (W), and patient episode (E) levels.
£Statistically significant (superiority hypothesis, 2-tailed p < 0.05).
N/A, not applicable.